Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Laura, Hou"'
Autor:
Sean Hennessy, Rebecca A Hubbard, Vincent Lo Re, Dena M Carbonari, Claudia A Steiner, Yunping Zhou, Cheryl N McMahill-Walraven, Pamala A Pawloski, Laura Hou, Sarah K Dutcher, John G Connolly, Silvia Perez-Vilar, Terese A DeFor, Djeneba Audrey Djibo, Laura B Harrington, Maria E Kempner, Jennifer L Kuntz, Jolene Mosley, Andrew B Petrone, Allyson M Pishko, Meighan Rogers Driscoll, Noelle M Cocoros
Publikováno v:
BMJ Medicine, Vol 2, Iss 1 (2023)
Objective To measure the 90 day risk of arterial thromboembolism and venous thromboembolism among patients diagnosed with covid-19 in the ambulatory (ie, outpatient, emergency department, or institutional) setting during periods before and during cov
Externí odkaz:
https://doaj.org/article/2491d0112e4f451494c117e8637225d9
Autor:
Anton Pottegård, Rebecca E Ghosh, Robert W Platt, Efe Eworuke, HaNa Lee, Marie C Bradley, Ashish Rai, Peter Bjødstrup Jensen, Mayura Shinde, Laura Hou, Michael J Paterson, Judith C Maro, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Stephen Welburn
Publikováno v:
BMJ Open, Vol 13, Iss 4 (2023)
Objectives To examine valsartan, losartan and irbesartan usage and switching patterns in the USA, UK, Canada and Denmark before and after July 2018, when the first Angiotensin-Receptor-Blocker (ARB) (valsartan) was recalled.Design Retrospective cohor
Externí odkaz:
https://doaj.org/article/1a9e38df6e294a2abc497e762ff2c878
Autor:
Michael D, Kappelman, Sruthi, Adimadhyam, Laura, Hou, Audrey E, Wolfe, Samantha, Smith, Andrew L, Simon, Érick, Moyneur, Juliane S, Reynolds, Sengwee, Toh, Angela, Dobes, Lauren E, Parlett, Kevin, Haynes, Mano, Selvan, Qianli, Ma, Vinit, Nair, Jessica, Burris, Jennifer E, Dorand, Ghadeer K, Dawwas, James D, Lewis, Millie D, Long
Publikováno v:
American Journal of Gastroenterology. 118:674-684
Many patients with Crohn's disease (CD) lose response or become intolerant to antitumor necrosis factor (TNF) therapy and subsequently switch out of class. We compared the effectiveness and safety of ustekinumab to vedolizumab in a large, geographica
Autor:
Christine Y. Lu, Laura Hou, Joy Kolonoski, Andrew B. Petrone, Fang Zhang, Catherine Corey, Ting‐Ying Huang, Marie C. Bradley
Publikováno v:
Pharmacoepidemiology and Drug Safety. 32:298-311
Develop and test a flexible, scalable tool using interrupted time series (ITS) analysis to assess the impact of Food and Drug Administration (FDA) regulatory actions on drug use.We applied the tool in the Sentinel Distributed Database to assess the i
Autor:
Michael Kappelman, James Lewis, Xian Zhang, Gil Melmed, Corey Siegel, Emily Cerciello, Angela Dobes, Alandra Weaver, Laura Weisbein, Lauren Parlett, Kevin Haynes, Mano Selvan, Qianli Ma, Vinit Nair, Sruthi Adimadhyam, Laura Hou, Audrey Wolfe, Darren Toh, Jessica Burris, Jennifer Dorand, Millie Long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82b75c3882ffa115639086ca876ce035
https://doi.org/10.25302/03.2023.pacr.2017c28172ic-c19
https://doi.org/10.25302/03.2023.pacr.2017c28172ic-c19
Validation of diagnosis codes to identify hospitalized COVID ‐19 patients in health care claims data
Autor:
Sheryl A. Kluberg, Laura Hou, Sarah K. Dutcher, Monisha Billings, Brian Kit, Sengwee Toh, Sascha Dublin, Kevin Haynes, Annemarie Kline, Mahesh Maiyani, Pamala A. Pawloski, Eric S. Watson, Noelle M. Cocoros
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:476-480
Health plan claims may provide complete longitudinal data for timely, real-world population-level COVID-19 assessment. However, these data often lack laboratory results, the standard for COVID-19 diagnosis.We assessed the validity of ICD-10-CM diagno
Autor:
Efe Eworuke, Mayura Shinde, Laura Hou, Michael J Paterson, Peter Bjødstrup Jensen, Judith C Maro, Ashish Rai, Daniel Scarnecchia, Dinci Pennap, Daniel Woronow, Rebecca E Ghosh, Stephen Welburn, Anton Pottegard, Robert W Platt, Hana Lee, Marie C Bradley
Publikováno v:
BMJ Open. 13:e070985
ObjectivesTo examine valsartan, losartan and irbesartan usage and switching patterns in the USA, UK, Canada and Denmark before and after July 2018, when the first Angiotensin-Receptor-Blocker (ARB) (valsartan) was recalled.DesignRetrospective cohort
Autor:
Michael Kappelman, Sruthi Adimadhyam, Laura Hou, Andrew L. Simon, Angela Dobes, Lauren E. Parlett, Kevin Haynes, Mano Selvan, Qianli Ma, Vinit Nair, Jessica L. Burris, Jennifer E. Dorand, Millie Long
Publikováno v:
American Journal of Gastroenterology. 117:e519-e520
Autor:
Judith C. Maro, Michael D. Nguyen, Laura Hou, Efe Eworuke, Sengwee Toh, Rima Izem, Bruce Fireman, Emily C. Welch, Joo‐Yeon Lee, Margie R. Goulding
Publikováno v:
Pharmacoepidemiology and Drug Safety. 29:1331-1335
Publikováno v:
Pharmacoepidemiology and Drug Safety. 29:409-418
Purpose The CHA2 DS2 -VaSc and HAS-BLED risk scores are commonly used in the studies of oral anticoagulants (OACs). The best ways to map these scores to the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) co